Randomized phase I and pharmacological study of weekly or 2-weekly gemcitabine and cisplatin in advanced non-small cell lung cancer

Por Crul, M, Schoemaker, N, Baas, P, Pluim, D, Sparidans, R, Beijnen, J H, Van Zandwijk, N, Schellens, J H M
Publicado em 2002

Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma: a retrospective analysis

Por Sombogaard, F., Franssen, E. J. F., Terpstra, W. E., Kerver, E. D., van den Berk, G. E. L., Crul, M.
Publicado no Int J Clin Pharm (2018)

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced soli...

Por Siegel-Lakhai, W S, Crul, M, Zhang, S, Sparidans, R W, Pluim, D, Howes, A, Solanki, B, Beijnen, J H, Schellens, J H M
Publicado em 2005